“I think as technology evolves, we as urologists need to continue to evolve and make changes to our practice,” says Kevin T. Keating, DO.
In this video, Matthew A. Rohloff, DO, and Kevin T. Keating, DO, discuss findings from the Urology Practice study, “Are Postoperative Laboratory Studies Following Robotic Assisted Radical Prostatectomy Necessary?” for which they served as study authors. Rohloff and Keating are urology residents at Metro Health – University of Michigan Health, Wyoming, Michigan.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.